Related Experiment Video
Updated: May 23, 2026
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
[Metabolic changes in prepuberty children with extrauterine growth restriction]
M Ortiz Espejo1, M Gil Campos, M C Muñoz Villanueva
1Unidad de Metabolismo e Investigación Pediátrica, Hospital Universitario Reina Sofía, Córdoba, España.
Anales De Pediatria (Barcelona, Spain : 2003)
|April 13, 2012
Summary
Children with extrauterine growth restriction (EUGR) show significant anthropometric, blood pressure, and metabolic changes in prepuberty. Early nutritional monitoring and long-term follow-up are crucial for managing these growth and metabolic alterations.
Area of Science:
- Pediatric Endocrinology
- Neonatal Nutrition
- Growth and Development
Context:
- Extrauterine growth restriction (EUGR) in infancy is linked to nutritional deficits.
- These deficits may predispose children to metabolic issues later in life, similar to intrauterine growth restriction.
Purpose:
- To investigate anthropometric, blood pressure, and metabolic profiles in prepubertal children with a history of EUGR.
- To compare these parameters with a control group of healthy children.
Summary:
- Prepubertal children with EUGR exhibited significantly lower height and BMI, and higher systolic and diastolic blood pressure compared to controls.
- The EUGR group also showed higher glucose levels and lower HDL cholesterol, though not clinically significant.
Impact:
- Identifies key health alterations in children with EUGR during prepuberty.
- Highlights the need for optimized perinatal nutrition and continued pediatric follow-up to mitigate long-term health risks associated with EUGR.
Related Concept Videos
01:27Signs of Puberty
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:10Nature and Nurture
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...